Citigroup’s Franklin Genomic Advancements ETF HELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-15
Closed -$491 4823
2024
Q1
$491 Buy
+15
New +$491 ﹤0.01% 4664